Thomas Broggini

Affiliations: 
2008-2011 Cell Biology & Neurobiology Charité - Universitätsmedizin Berlin, Germany 
Google:
"Thomas Broggini"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kratzsch T, Piffko A, Broggini T, et al. (2020) Role of mTOR and VEGFR Inhibition in Prevention of Metastatic Tumor Growth in the Spine. Frontiers in Oncology. 10: 174
Uhl C, Markel M, Broggini T, et al. (2018) EphB4 mediates resistance to antiangiogenic therapy in experimental glioma. Angiogenesis
Acker G, Piper SK, Datwyler AL, et al. (2018) Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma. Oncotarget. 9: 27760-27772
Bayerl SH, Nieminen-Kelhä M, Broggini T, et al. (2016) Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice. Journal of Visualized Experiments : Jove
Broggini T, Schnell L, Ghoochani A, et al. (2016) Plasticity Related Gene 3 (PRG3) overcomes myelin-associated growth inhibition and promotes functional recovery after spinal cord injury. Aging. 8: 2463-2487
Broggini T, Piffko A, Hoffmann CJ, et al. (2016) Passive Entrapment of Tumor Cells Determines Metastatic Dissemination to Spinal Bone and Other Osseous Tissues. Plos One. 11: e0162540
Fan Z, Bittermann-Rummel P, Yakubov E, et al. (2016) PRG3 induces Ras-dependent oncogenic cooperation in gliomas. Oncotarget
Savaskan NE, Fan Z, Broggini T, et al. (2015) Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight. Current Neuropharmacology. 13: 258-65
Broggini T, Wüstner M, Harms C, et al. (2015) NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment. Cancer Letters
Broggini T, Czabanka M, Piffko A, et al. (2015) ICAM1 depletion reduces spinal metastasis formation in vivo and improves neurological outcome. European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
See more...